SynuCa Therapeutics

Aarhus, Denmark

Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.

$1.5M raised

Mar 2026

Seed

Medical Neuroscience Therapeutics

Top Investors

BioInnovation Institute Venture Lab

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SynuCa Therapeutics

How much funding has SynuCa Therapeutics raised?

SynuCa Therapeutics has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in March 2026.

Who are SynuCa Therapeutics's investors?

SynuCa Therapeutics's investors include BioInnovation Institute Venture Lab.

Where is SynuCa Therapeutics headquartered?

SynuCa Therapeutics is headquartered in Aarhus, Denmark.

What does SynuCa Therapeutics do?

Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly Parkinson's disease.

What stage is SynuCa Therapeutics at?

SynuCa Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 2, 2026.

MLA

"SynuCa Therapeutics — Funding & Investors." VCBacked, March 2, 2026, https://www.vcbacked.co/company/synuca-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). SynuCa Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/synuca-therapeutics

Wikipedia (cite web)

{{cite web |title=SynuCa Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/synuca-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 2, 2026.

Similar Companies in Medical

Advanced Microbiome Interventions

Amsterdam$300K